243 related articles for article (PubMed ID: 21034366)
1. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
Sandri G; Bonferoni MC; Gökçe EH; Ferrari F; Rossi S; Patrini M; Caramella C
J Microencapsul; 2010; 27(8):735-46. PubMed ID: 21034366
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
Gokce EH; Sandri G; Bonferoni MC; Rossi S; Ferrari F; Güneri T; Caramella C
Int J Pharm; 2008 Nov; 364(1):76-86. PubMed ID: 18725276
[TBL] [Abstract][Full Text] [Related]
3. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
6. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
7. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
[TBL] [Abstract][Full Text] [Related]
8. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
Hu FQ; Wu MZh; Yuan H; Zhang HH
Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749
[TBL] [Abstract][Full Text] [Related]
9. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
10. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
Singh KH; Shinde UA
Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.
Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N
Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299
[TBL] [Abstract][Full Text] [Related]
12. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes.
Haidar ZS; Hamdy RC; Tabrizian M
Biomaterials; 2008 Mar; 29(9):1207-15. PubMed ID: 18076987
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
Hu LD; Tang X; Cui FD
Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
[TBL] [Abstract][Full Text] [Related]
14. Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.
Chen Y; Lu Y; Zhong Y; Wang Q; Wu W; Gao S
J Drug Target; 2012 Dec; 20(10):856-63. PubMed ID: 23050903
[TBL] [Abstract][Full Text] [Related]
15. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
Aji Alex MR; Chacko AJ; Jose S; Souto EB
Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
[TBL] [Abstract][Full Text] [Related]
16. Development, characterization and in vitro assessement of stearylamine-based lipid nanoparticles of paclitaxel.
Pandita D; Ahuja A; Lather V; Dutta T; Velpandian T; Khar RK
Pharmazie; 2011 Mar; 66(3):171-7. PubMed ID: 21553646
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
18. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin.
Senyiğit T; Sonvico F; Barbieri S; Ozer O; Santi P; Colombo P
J Control Release; 2010 Mar; 142(3):368-73. PubMed ID: 19932722
[TBL] [Abstract][Full Text] [Related]
19. Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Boselli C; Caramella C
AAPS PharmSciTech; 2010 Mar; 11(1):362-71. PubMed ID: 20232266
[TBL] [Abstract][Full Text] [Related]
20. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
